Engineered Cell Therapy Shrinks Advanced Kidney Cancer in One Teenager
โฎ BeforeAdvanced kidney cancer in this teenager had no effective option described in the source.
โ
NowThe engineered T-cell therapy produced a deep response in this patient.
In short
- An engineered T-cell therapy produced a deep response in a teenager with advanced kidney cancer.
- The treatment was designed for one patient, an approach sometimes called N-of-1.
- The source also notes the limits of personalised treatment, which is hard to scale.
Why it's good news
The result is from a single patient, so it is an early signal rather than proof. Personalised cell therapies are costly and slow to make, and the source points to those limits. Still, a deep response in a teenager with advanced disease is a meaningful step for treatment design.
Advertisement
From Forbes
Engineered T-cell therapy produced a deep response in a teenager with advanced kidney cancer, highlighting the promise and limits of personalized treatment.
Ask this story
More like this
Advertisement